ADVERTISEMENT

Clinical Summary

COVID-19: early treatment with inexpensive antidepressant prevents hospitalization of high-risk patients

Reis G & al.. Lancet Glob Health, 27 October 2021
Miriam Davis, PhD   |   11 November 2021

Takeaway

  • Early treatment with the antidepressant fluvoxamine prevents hospitalization of high-risk symptomatic adults with COVID-19 in the TOGETHER randomized, platform clinical trial.

Why this matters

  • This study confirms a smaller randomized controlled trial.
  • Fluvoxamine is an inexpensive treatment that will be highly useful in developing countries.

Study design

  • Placebo-controlled, randomized,...

          

November Challenge

Ends in 10h
left
right

Topic Challenges

left
right